CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
NASDAQ: CUPR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.25
-6.08% today
Updated 2026-04-30
Market cap
$6.66M
P/E ratio
—
P/S ratio
219.66x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$0 – $10
Volume
2.3M
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $58504.00 | $56599.00 | $100773.00 | $48321.00 | $49894.00 |
| Revenue growth (YoY) | — | -3.3% | +78.0% | -52.0% | +3.3% |
| Cost of revenue | $35447.00 | $36621.00 | $64168.00 | $51345.00 | $50539.00 |
| Gross profit | $23057.00 | $19978.00 | $36605.00 | $-3024.00 | $-645.00 |
| Gross margin | 39.4% | 35.3% | 36.3% | -6.3% | -1.3% |
| R&D | $279785.00 | $292879.00 | $167734.00 | $241362.00 | $226884.00 |
| SG&A | $248099.00 | $790634.00 | $826704.00 | $1.26M | $4.39M |
| Operating income | $-552752.00 | $-1.18M | $-1.07M | $-1.65M | $-4.57M |
| Operating margin | -944.8% | -2077.4% | -1060.1% | -3404.9% | -9154.6% |
| EBITDA | $-489445.00 | $-1.06M | $-994121.00 | $-1.43M | — |
| EBITDA margin | -836.6% | -1865.9% | -986.5% | -2957.7% | 0.0% |
| EBIT | $-516903.00 | $-1.09M | $-1.03M | $-1.47M | — |
| Interest expense | $2783.00 | $2017.00 | $56587.00 | $37210.00 | $14724.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-519686.00 | $-1.09M | $-1.12M | $-1.56M | $-4.67M |
| Net income growth (YoY) | — | -110.6% | -2.3% | -39.4% | -199.5% |
| Profit margin | -888.3% | -1933.8% | -1111.0% | -3229.5% | -9366.8% |